| 000 | 00990 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517002229.0 | ||
| 264 | 0 | _c20150519 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1996-3181 | ||
| 024 | 7 |
_a10.2174/1871527313666141110125829 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFayaz, S M | |
| 245 | 0 | 0 |
_aATF4: the perpetrator in axonal-mediated neurodegeneration in Alzheimer's disease. _h[electronic resource] |
| 260 |
_bCNS & neurological disorders drug targets _c2014 |
||
| 300 |
_a1483-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aActivating Transcription Factor 4 _xanalysis |
| 650 | 0 | 4 |
_aAlzheimer Disease _xpathology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aRajanikant, G K | |
| 773 | 0 |
_tCNS & neurological disorders drug targets _gvol. 13 _gno. 9 _gp. 1483-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1871527313666141110125829 _zAvailable from publisher's website |
| 999 |
_c24340552 _d24340552 |
||